Brilinta
Ticagrelor 60mg and 90mg film-coated tablets, used in the management of acute coronary syndrome. A P2Y12 antagonist that damps platelet aggregation.
- Category
- Heart & Blood Pressure
- Active ingredient
- Ticagrelor
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 60 · 90mg
You will receive a quality generic equivalent, depending on stock.
Prescription rules on Brilinta vary by country.
Brilinta details
- Condition
- Acute Coronary Syndrome
- Alternative names
- Brilique
- Therapeutic class
- Platelet Aggregation Inhibitor
- Pharmacological class
- P2Y12 Receptor Antagonist
- Contraindications
- active bleeding; history of intracranial haemorrhage; severe hepatic impairment
- Precautions and warnings
- risk of bleeding; inform medical staff before surgery; monitor for dyspnoea
- Minor side effects
- dyspnoea; bruising
- Moderate side effects
- epistaxis; gastrointestinal haemorrhage
- Serious side effects
- intracranial haemorrhage, requires immediate medical attention
- Dosage forms
- Film-coated tablet
- Administration route
- Oral use
- Supply category
- Pharmacist only, dispensed without a prescription
- Originator
- AstraZeneca
- Onset Time
- 30–60 minutes
- Duration
- 12 hours
- Storage instructions
- Store below 30°C.
- Drug interactions
- aspirin; clopidogrel; ketoconazole
- Pregnancy and breastfeeding
- Pregnancy: not recommended. Breastfeeding: not recommended.
Patient summary
Ticagrelor 60mg and 90mg film-coated tablets, used in the management of acute coronary syndrome. A P2Y12 antagonist that damps platelet aggregation.
Mechanism of action
Reduces the risk of clots by inhibiting the P2Y12 platelet receptor, thereby reducing platelet aggregation.
What you will receive
Brilinta is the originator brand name, made by AstraZeneca. We use it here to identify the medicine only; we are not affiliated with AstraZeneca and do not ship the original Brilinta.
- You receive a generic equivalent: the same active ingredient (Ticagrelor) at the same dose, mostly recognised Indian branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- A regulated generic matches the original ingredient for ingredient by legal standard.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Brilinta
Brilinta is the primary brand of ticagrelor, a medication used for the management of Acute Coronary Syndrome. This pharmaceutical is also sold under the brand name Brilique. It is supplied as a tablet in strengths of 60mg and 90mg for clinical use.
Buying Brilinta online
Brilinta is registered across 13 markets including Malaysia, the Philippines and Indonesia, with availability also in Taiwan, South Korea and Japan. Generic ticagrelor, much of it made in India, is far more affordable than the original AstraZeneca product, helping expats and people far from a major pharmacy maintain their treatment. This is one of the most ordered medications across the region and can be ordered online for delivery throughout our service network.